Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply by Authors.
Rachubinski P, Witt JH, Budäus L, Zinke J, Fangmeyer B, Spieker T, Vetterlein M, Rahbar K, Kachanov M, Leyh-Bannurah SR. Rachubinski P, et al. Among authors: zinke j. J Urol. 2022 Dec;208(6):1213. doi: 10.1097/JU.0000000000002921.04. Epub 2022 Dec 1. J Urol. 2022. PMID: 36349926 No abstract available.
Perioperative and Postoperative Outcomes of Robot-Assisted Radical Prostatectomy in Prostate Cancer Patients with Prior Transurethral Subvesical Deobstruction: Results of a High-Volume Center.
Leyh-Bannurah SR, Liakos N, Oelke M, Wagner C, Schuette A, Fangmeyer B, Zinke J, Wasiri D, Mendrek M, Witt JH. Leyh-Bannurah SR, et al. Among authors: zinke j. J Urol. 2021 Aug;206(2):308-318. doi: 10.1097/JU.0000000000001776. Epub 2021 Apr 27. J Urol. 2021. PMID: 33904761
Reply By Authors.
Leyh-Bannurah SR, Liakos N, Oelke M, Wagner C, Schuette A, Fangmeyer B, Zinke J, Wasiri D, Mendrek M, Witt JH. Leyh-Bannurah SR, et al. Among authors: zinke j. J Urol. 2021 Aug;206(2):317-318. doi: 10.1097/JU.0000000000001776.02. Epub 2021 May 7. J Urol. 2021. PMID: 33960812 No abstract available.
Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy.
Kachanov M, Budäus L, Witt JH, Wagner C, Zinke J, Fangmeyer B, Schütte A, Spieker T, Beyersdorff D, Graefen M, Rachubinski P, Leyh-Bannurah SR. Kachanov M, et al. Among authors: zinke j. World J Urol. 2022 Dec;40(12):2955-2961. doi: 10.1007/s00345-022-04207-9. Epub 2022 Nov 11. World J Urol. 2022. PMID: 36357604 Free PMC article.
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
Sheth KN, Albers GW, Saver JL, Campbell BCV, Molyneaux BJ, Hinson HE, Cordonnier C, Steiner T, Toyoda K, Wintermark M, Littauer R, Collins J, Lucas N, Nogueira RG, Simard JM, Wald M, Dawson K, Kimberly WT; CHARM Trial investigators. Sheth KN, et al. Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3. Lancet Neurol. 2024. PMID: 39577921 Clinical Trial.
75 results